Long-lived B cell Immunity in the Respiratory Tract

呼吸道中的长寿命 B 细胞免疫

基本信息

  • 批准号:
    8316175
  • 负责人:
  • 金额:
    $ 37.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Respiratory tract infections induce strong and long-lasting humoral immune responses locally at the site, contributing significantly to immune protection from challenge infection. The mechanisms that induce and control protective local immune responses are currently not fully understood. The study is based on preliminary data in mice that implicate the rapidly induced extrafollicular foci B cell response as source for long-lived humoral immunity in the respiratory tract following influenza virus infection. The objective for this proposal is to identify the mechanisms that regulate this long-term local antibody response to influenza virus in the respiratory tract. In Specific Aim #1 the differentiation pathways and protective capacity of lung antibody-secreting cells following influenza virus infection will be measured in wildtype mice and in mice that lack formation of germinal centers (SAP-/- mice) or strong extrafollicular foci responses (following inactivated virus delivery) using BLIMP-1 reporter mice and a newly developed system for tracking of influenza hemagglutinin-specific, C12Id-expressing B cells ex vivo. Specific Aim #2 will study the mechanisms regulating the migration/retention of lung plasma cell precursors to the respiratory tract. They will assess the extent to which migration of virus-specific B cells/plasma cells from regional lymph nodes is required for the establishment of lung tissue plasma cell pools, and using genetic screening and a custom microfluidics device, will identify the integrins and chemokines/receptors responsible for the selective accumulation and/or retention of plasma cells the lung tissue under shear stress. Specific Aim #3 will use gene expression studies to determine the differentiation stage of plasma cells/precursors in the lung tissue and BrDU labeling studies to identify the mechanisms underlying the longevity of the antibody-secreting cells in the lung. Adoptive transfer studies will assess the requirements for antigen and/or infection-induced inflammatory signals for their maintenance. These studies will provide novel information on the characteristics and the B cell developmental pathways that generate the long-lived humoral immune responses in the respiratory tract, basic knowledge on B cell response regulation that can aid rationale vaccine design. PUBLIC HEALTH RELEVANCE: Protection from infections with influenza virus is contributed at least in part by antibody-secreting cells that establish in the lung following influenza virus infection. This study aims to understand how these cells are generated and what regulates their migration/maintenance in the lung. This basic information will provide potential avenues for rational vaccine design that aims to boost local/mucosal immune responses.
描述(由申请人提供):呼吸道感染在该部位诱发强烈且持久的局部体液免疫反应,对抵抗攻击性感染的免疫保护有显着贡献。目前尚未完全了解诱导和控制保护性局部免疫反应的机制。该研究基于小鼠的初步数据,这些数据表明快速诱导的滤泡外病灶 B 细胞反应是流感病毒感染后呼吸道中长效体液免疫的来源。该提案的目的是确定调节呼吸道中流感病毒长期局部抗体反应的机制。在具体目标#1中,将使用BLIMP-1报告小鼠和新开发的流感追踪系统,在野生型小鼠和缺乏生发中心形成的小鼠(SAP-/-小鼠)或强滤泡外病灶反应(灭活病毒递送后)中测量流感病毒感染后肺部抗体分泌细胞的分化途径和保护能力 血凝素特异性、表达 C12Id 的 B 细胞离体。具体目标#2将研究调节肺浆细胞前体向呼吸道迁移/保留的机制。他们将评估建立肺组织浆细胞库所需的病毒特异性 B 细胞/浆细胞从区域淋巴结迁移的程度,并使用基因筛查和定制微流体装置,将识别负责浆细胞在剪切应力下选择性积累和/或保留肺组织的整合素和趋化因子/受体。具体目标#3将利用基因表达研究来确定肺组织中浆细胞/前体的分化阶段,并利用BrDU标记研究来确定肺中抗体分泌细胞长寿的机制。过继转移研究将评估其维持所需的抗原和/或感染诱导的炎症信号。这些研究将提供有关在呼吸道中产生长效体液免疫反应的特征和 B 细胞发育途径的新信息,以及有助于疫苗设计合理性的 B 细胞反应调节的基础知识。 公共卫生相关性:流感病毒感染后肺部建立的抗体分泌细胞至少部分有助于防止流感病毒感染。这项研究旨在了解这些细胞是如何产生的,以及是什么调节它们在肺部的迁移/维持。这些基本信息将为旨在增强局部/粘膜免疫反应的合理疫苗设计提供潜在途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicole Baumgarth其他文献

Nicole Baumgarth的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicole Baumgarth', 18)}}的其他基金

Antibody-mediated immunity to Borrelia burgdorferi
抗体介导的伯氏疏螺旋体免疫
  • 批准号:
    10368140
  • 财政年份:
    2021
  • 资助金额:
    $ 37.6万
  • 项目类别:
Antibody-mediated immunity to Borrelia burgdorferi
抗体介导的伯氏疏螺旋体免疫
  • 批准号:
    10559504
  • 财政年份:
    2021
  • 资助金额:
    $ 37.6万
  • 项目类别:
Antibody-mediated immunity to Borrelia burgdorferi
抗体介导的伯氏疏螺旋体免疫
  • 批准号:
    10731568
  • 财政年份:
    2021
  • 资助金额:
    $ 37.6万
  • 项目类别:
B-1 cells, IgM and Protective Humoral Immunity to Influenza
B-1 细胞、IgM 和流感保护性体液免疫
  • 批准号:
    10681028
  • 财政年份:
    2019
  • 资助金额:
    $ 37.6万
  • 项目类别:
B-1 cells, IgM and Protective Humoral Immunity to Influenza
B-1 细胞、IgM 和流感保护性体液免疫
  • 批准号:
    10023157
  • 财政年份:
    2019
  • 资助金额:
    $ 37.6万
  • 项目类别:
Protective humoral immunity to influenza infection
对流感感染的保护性体液免疫
  • 批准号:
    9196008
  • 财政年份:
    2016
  • 资助金额:
    $ 37.6万
  • 项目类别:
Long-lived B cell Immunity in the Respiratory Tract
呼吸道中的长寿命 B 细胞免疫
  • 批准号:
    8521064
  • 财政年份:
    2010
  • 资助金额:
    $ 37.6万
  • 项目类别:
Long-lived B cell Immunity in the Respiratory Tract
呼吸道中的长寿命 B 细胞免疫
  • 批准号:
    8134252
  • 财政年份:
    2010
  • 资助金额:
    $ 37.6万
  • 项目类别:
Regulation of Humoral Immunity to Influenza Virus
流感病毒体液免疫的调节
  • 批准号:
    8068104
  • 财政年份:
    2010
  • 资助金额:
    $ 37.6万
  • 项目类别:
Long-lived B cell Immunity in the Respiratory Tract
呼吸道中的长寿命 B 细胞免疫
  • 批准号:
    8009552
  • 财政年份:
    2010
  • 资助金额:
    $ 37.6万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 37.6万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 37.6万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 37.6万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.6万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了